A detailed history of Investment Management Corp Of Ontario transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Investment Management Corp Of Ontario holds 6,300 shares of BMRN stock, worth $399,546. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,300
Previous 4,200 50.0%
Holding current value
$399,546
Previous $345,000 28.12%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $144,942 - $197,064
2,100 Added 50.0%
6,300 $442,000
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $89,316 - $110,664
1,200 Added 40.0%
4,200 $345,000
Q1 2024

May 15, 2024

SELL
$83.81 - $99.0 $117,334 - $138,600
-1,400 Reduced 31.82%
3,000 $262,000
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $335,368 - $433,444
4,400 New
4,400 $424,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Investment Management Corp Of Ontario Portfolio

Follow Investment Management Corp Of Ontario and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Management Corp Of Ontario, based on Form 13F filings with the SEC.

News

Stay updated on Investment Management Corp Of Ontario with notifications on news.